[Clinical analysis of multiple myeloma with second primary malignancies and multiple myeloma secondary to malignancies].

Leng, Y; Wang, H J; Zhou, H X; Zhang, Z Y; Chen, W M

Leng, Y; Wang, H J; Zhou, H X; Zhang, Z Y; Chen, W M.

Afiliación

Leng Y; Department of Hematology, Beijng Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Wang HJ; Department of Hematology, Beijng Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhou HX; Department of Hematology, Beijng Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhang ZY; Department of Hematology, Beijng Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Chen WM; Department of Hematology, Beijng Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

Zhonghua Yi Xue Za Zhi ; 102(32): 2523-2529, 2022 Aug 30.

Article en Zh | MEDLINE | ID: mdl-36008323

Asunto(s)

Neoplasias Hematológicas; Mieloma Múltiple; Neoplasias Primarias Secundarias; Neoplasias Urogenitales; Femenino; Humanos; Masculino; Mieloma Múltiple/tratamiento farmacológico; Mieloma Múltiple/patología; Neoplasias Primarias Secundarias/diagnóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Urogenitales / Neoplasias Primarias Secundarias / Neoplasias Hematológicas / Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google